Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIVC Study of Pramipexole SR Tablets
NCT02260024Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2005
- Primary completion
- Dec 2005
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of pramipexole in Parkinson's disease (PD) (6 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the concentration time curve 0-30h and Maximum measured concentration at 30 hours. Started Oct 2005; status: completed.
02
Drugs
pramipexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02260024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02260024.